摘要:
The present invention describes novel radiopharmaceuticals of formula (I), wherein J, K, L, and M are amino acids or derivatives thereof and R', R1, R2 and n are as defined herein, that are radiolabeled cyclic compounds containing chelators which act as antagonists of the platelet glycoprotein IIb/IIIa complex, methods of using the same as imaging agents for the diagnosis of arterial and venous thrombi, and novel reagents for the preparation of the same and kits comprising the reagents.
摘要:
The present application describes amidinoindoles, amidinoazoles, and analogs thereof of formula (I): wherein W, W?1, W2, and W3¿ are selected from CH and N, provided that one of W?1 and W2¿ is C(C(=NH)NH¿2?) and at most two of W, W?1, W2, and W3¿ are N and one of J?a and Jb¿ is substituted by -(CH¿2?)n-Z-A-B, which are useful as inhibitors of factor Xa or thrombin.
摘要:
The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula (I) or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is N or NH and D may be C(=NH)NH2, which are useful as inhibitors of factor Xa.
摘要:
This invention relates to novel fused heterocycles which are useful as antagonists of the αvβ3 and related integrin receptors of Formula (I), to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of cell adhesion, the treatment of angiogenic disorders, inflammation, bone degradation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration, and other conditions mediated by cell adhesion and/or cell migration and/or angiogenesis.
摘要:
The present invention relates to compounds of formula (I) or pharmaceutically acceptable salt forms or prodrugs thereof, which are useful as inhibitors of HIV protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
摘要:
Novel compounds and pharmaceutical compositions thereof, and methods of using same in treating anxiety, depression, and other psychiatric and neurological disorders. The novel compounds provided by this invention are those of formulae (I), (II) wherein R1, R13, X, Y, Z, G and Q are as defined herein.
摘要:
The present application desscribes inhibitors of factor Xa which are cyano-pyrazole, cyano-triazole, cyano-imidazole, and cyano-pyrrole compounds of Formulae (Ia), (Ib), (Ic), and (Id): or pharmaceutically acceptable salt forms thereof.
摘要:
The present invention relates to 1,4-benzodiazepin-2-ones of Formula (I) or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
摘要:
The present application describes aryl sulfonyls of formula (I) or pharmaceutically acceptable salt or prodrug forms thereof, wherein D, E, and M are defined below, are effective factor Xa inhibitors.
摘要:
This invention relates generally to N-adamant-1-yl-N'-[4-chlorobenzolthiazol-2-yl] urea, pharmaceutical compositions comprising the same, and methods of using the same in the treatment of inflammation and as an anticancer radiosensitizing agent.